课题基金 / 基金详情

Dev Proj 2: Optical Dissection of a Lung Cancer Tumor Suppressor Gene

Dev Proj 2: Optical Dissection of a Lung Cancer Tumor Suppressor Gene
开发项目 2:肺癌肿瘤抑制基因的光学解剖
批准号:
7287015
负责人:
Adam I. Marcus
金额:
$3.82万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-04-01 至 2010-08-31
关键词:
3-DimensionalA549Abnormal CellActin-Binding ProteinActinsAnimalsAppearanceAreaBiological AssayBiological MarkersBlindedBreastBreast CarcinomaCancer PatientCarcinomaCell PolarityCell membraneCellsCessation of lifeClinical TrialsCytochalasin DCytoskeletonDataDefectDiffuseDissectionDoctor of PhilosophyE-CadherinE-Cadherin Staining MethodEnvironmentEpithelialEpithelial CellsEventFibronectinsFigs - dietaryFluorescenceFluorescence Recovery After PhotobleachingFutureGalactoseGoalsGolgi ApparatusGreen Fluorescent ProteinsGrowthHumanImageImage AnalysisImmunohistochemistryIn SituIncubatedInvadedInvasiveIonsKineticsLasersLifeLocalizedLung NeoplasmsMalignant - descriptorMalignant NeoplasmsMalignant neoplasm of lungMatrigel Invasion AssayMediatingMesenchymalMicroscopeModelingMotorMovementMutateMutationNeoplasm MetastasisNon-Small-Cell Lung CarcinomaNuclearOpticsParaffin EmbeddingPathologistPathologyPatientsPharmaceutical PreparationsPhase-Contrast MicroscopyPhenotypePhosphotransferasesPhotobleachingPilot ProjectsPlatelet-Derived Growth FactorPlayPositioning AttributePrimary NeoplasmProliferatingProtein OverexpressionProteinsRateRecoveryRecruitment ActivityRoleSTK11 geneSample SizeSamplingSeriesSignal TransductionSignaling MoleculeSlideSmall Interfering RNASolutionsSpecimenStaining methodStainsTestingTherapeuticTimeTissue MicroarrayTissuesTolonium chlorideTransferaseTumor Cell InvasionTumor Suppressor GenesTumor-Suppressor Gene InactivationVimentinbasecancer cellcell fixingcell motilitycellular imagingdata managementdepolymerizationfluorophoreimage processingin vivointerestmigrationmutantpolarized cellpolymerizationprogramsresearch studyspatiotemporaltime usetissue fixingtranslational studytumorwound

项目摘要

项目成果

Adam I. Marcus的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Pilot Project 2: Optical dissection of a lung cancer tumor suppressor gene PI: Adam I. Marcus, PhD Tumor metastasis is the primary cause of patient death in almost all cancers. Attempts at developing a therapeutic strategy that can block metastasis is limited by our understanding of how stationary cancer cells transform into malignant carcinomas. It is already known that one key step is the inactivation of tumor suppressor genes, which allows cancer cells to continuously proliferate and eventually metastasize. In nonsmall cell lung cancer (NSCLC) the tumor suppressor gene, LKB1 is mutated in 30% of all primary tumors. A series of studies in normal epithelial cells implicate LKB1 as a master regulator of epithelial cell polarity raising the possibility that in NSCLC, LKB1 loss triggers an aberrant cell polarity program and subsequent cell invasion. Interestingly, our preliminary data implicate LKB1 in NSCLC motility and migration; therefore, we will test the hypothesis that LKB1 loss in NSCLC eliminates the activity of this suppressor and triggers cancer cell invasion. These studies will rely on live cell confocal imaging to determine how LKB1 mediates NSCLC invasion. Importantly, these mechanistic initiatives will be bridged with more translational studies investigating the impact of LKB1 loss on cancer cell invasion
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Project 3: Inhibiting FAK to enhance immune checkpoint inhibitor therapy in LKB1-mutant lung adenocarcinoma
  • 批准号:
    10411668
  • 项目类别:
  • 资助金额:
    $54.89万
  • 财政年份:
    2022
  • 负责人:
    Adam I. Marcus
  • 依托单位:
Cleared Tissue Large FOV Microscope Request
  • 批准号:
    10429884
  • 项目类别:
  • 资助金额:
    $30.84万
  • 财政年份:
    2022
  • 负责人:
    Adam I. Marcus
  • 依托单位:
Project 3: Inhibiting FAK to enhance immune checkpoint inhibitor therapy in LKB1-mutant lung adenocarcinoma
  • 批准号:
    10631151
  • 项目类别:
  • 资助金额:
    $56.99万
  • 财政年份:
    2022
  • 负责人:
    Adam I. Marcus
  • 依托单位:
Implications of metabolic heterogeneity on collective lung cancer cell invasion
  • 批准号:
    10383657
  • 项目类别:
  • 资助金额:
    $44.14万
  • 财政年份:
    2021
  • 负责人:
    Adam I. Marcus
  • 依托单位:
国内基金
海外基金
基于多重精准选择性碳氢官能化合成策略的抗A549/HepG2活性先导化合物发现及其作用靶标研究
  • 批准号:
    22007020
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2020
  • 负责人:
    周志
  • 依托单位:
导向抗HepG2/A549先导化合物发现和结构优化的多重精准选择性C-H键官能化反应研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2019
  • 负责人:
    周志
  • 依托单位:
内蒙古白云鄂博稀土矿区大气可吸入颗粒物对A549细胞毒理研究
  • 批准号:
    81473017
  • 项目类别:
    面上项目
  • 资助金额:
    66.0万元
  • 批准年份:
    2014
  • 负责人:
    孙涓
  • 依托单位:
用于识别癌细胞A549的磁共振和荧光双功能探针的研究